MetaCurUm Biotech has won an innovation competition announced by Groth & Co. MetaCurUm Biotech develops a new treatment of aggressive cancer. The company is a spin-off from Umeå University and
Vaisala has provided the hospital with measurement instruments for monitoring humidity, carbon dioxide, and temperature. Furthermore, Vaisala’s viewLinc Continuous Monitoring System monitors the conditions in the hospital’s vital tissue bank around the clock, every day of the year.
As the new Program Director of NLSDays, I am fortunate to be given a platform to address important issues within our life science community. In this medium, I would first
MetaCurUm Biotech has won an innovation competition announced by Groth & Co. MetaCurUm Biotech develops a new treatment of aggressive cancer. The company is a spin-off from Umeå University and
Zelluna Immunotherapy and Glycostem Therapeutics have announce that they have entered into a development, license and supply agreement. This collaboration will focus on the development and manufacture of allogeneic TCR
Business has been on Nikolaj Sørensen’s mind from an early age. Today, his leadership skills ranks high in employee surveys and he has been on a journey not many Nordic
UmanDiagnostics has signed a new licensing and supply agreement with global giant Siemens. “Siemens is a world leader in our industry, so this is an extremely important agreement for us,”
Researchers at Karolinska Institutet have shown that the memory capacity and learning capability of mice improve if lithium treatment is given after the irradiation of the brain. Mice that were
The European Commission (EC) has approved Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) modified-release tablets to improve glycaemic control in adults with type-2 diabetes (T2D). The approval is based on data
Recipharm and Consort Medical have reached an agreement on the terms of a recommended cash offer by Recipharm Holdings Limited, a wholly-owned direct subsidiary of Recipharm, for Consort. The Board
Continuous monitoring of an environment with a sensor during bio-decontamination allows you to decrease the number of indicators used in routine processes because there is accurate inline measurement data available.
During its first year the bioprocess pilot-scale facility in Uppsala has hosted fifteen national and international projects and more than 2 000 study visits. The not-for-profit innovation center and testbed
Scandinavian Biopharma reports successful results of the ETEC vaccine candidate ETVAX in a placebo-controlled phase I/II study in infants and children in Bangladesh. The successful results of the Phase I/II
Follicum has announced that the company has signed a collaboration agreement with proDERM for conducting the new clinical trial with a cream-like formulation of FOL-005 to be tested on alopecia
LIDDS licensee Jiangxi Puheng Pharma has after reviewing the preliminary results in LPC-004 decided to move ahead and has initiated discussions with Chinese medical authority, CFDA. The phase III study
Vaccibody has announced strong preliminary data from the ongoing VB N-01 phase I/IIa clinical trial of the VB10.NEO neoantigen cancer vaccine. The data is from the first 16 patients assessed
Pharmaceuticals in the environment is a growing problem of global concern. Drugs taken by humans and animals find their way into rivers, lakes and even drinking water and can have
IVL Swedish Environmental Research Institute and Simrishamn Municipality have tested a completley new treatment system that has now been added to the Stengården sewage plant in Simrishamn, Sweden. “Removing pharmaceutical
Nordic efforts to prevent pharmaceuticals affecting the environment include Danish management of hospital wastewater and a Swedish large-scale sewage plant for removal of pharmaceutical residues. Wastewater from hospitals can contain
Professor Honjo did not set out to find a cure for cancer but he is glad he did not give up and believes cancer immunotherapy will be the Number One
When your passion and lifelong work are the same. Great things can happen. Just ask James Allison.
The 2018 Nobel Prize in Medicine was awarded to James P. Allison and Tasuku Honjo for ther pioneering work in cancer immunotheraphy.
WHINN, the Week of Health and INNovation is a health tech and health innovation conference which attracts business people, decision makers, policy makers, clinicians, end-users and people with a general
The forum brings together the most senior experts from across Europe and beyond to provide an environment for meaningful interactions with those at the very forefront of precision oncology. With
This two day conference will feature company presentations from some of the leading Healthcare Companies in the Nordics, panel discussions, and inspiring key note speakers. The NALS conference attracts private and
This European partnering event focuses on early-stage deals and investment rounds in the life sciences field. BioFIT is a leading partnering event in Europe for technology transfer, academia-industry collaborations, early-stage
The Athera Board of Directors has announced that James Hall is the new Chief Executive Officer in the company. Carina Schmidt steps down after nearly 13 years as CEO but
Jonas Lindqvist brings with him decades of leadership experience in a regulated environment which was a critical factor in the selection process, states the company. As AMRA focuses on operational
Amy Arthur has been appointed new General Manager of Boehringer Ingelheim Sweden. During the past 16 years Arthur, originally from the UK, has been working within different areas of business
Noora Männikkö is a software designer focusing on healthcare applications. She likes working with something that can have a societal impact and she believes that digital health tools bring a
ISSUE 04 2019 // This issue features an exclusive interview with business woman Barbro Ehnbom, within life sciences perhaps best known as the founder of SALSS. This issue also contains a mini-theme on Drug development. We also reveal new Nordic findings from CryoEM data and we have spoken to Ed Boyden, the winner of the Lennart Nilsson Award.
Scandinavian Biopharma reports successful results of the ETEC vaccine candidate ETVAX in a placebo-controlled phase I/II study in infants and children in Bangladesh. The successful results of the Phase I/II
Follicum has announced that the company has signed a collaboration agreement with proDERM for conducting the new clinical trial with a cream-like formulation of FOL-005 to be tested on alopecia
LIDDS licensee Jiangxi Puheng Pharma has after reviewing the preliminary results in LPC-004 decided to move ahead and has initiated discussions with Chinese medical authority, CFDA. The phase III study
Vaccibody has announced strong preliminary data from the ongoing VB N-01 phase I/IIa clinical trial of the VB10.NEO neoantigen cancer vaccine. The data is from the first 16 patients assessed
LIDDS has received approval from authorities in Lithuania to conduct its Phase I study, NZ-DTX-001. The aim of the phase I dose escalation clinical trial is to assess the tolerability
Gedea Biotech reports that all 24 patients have been treated with its lead product, pHyph, a vaginal tablet for topical treatment of bacterial vaginosis in a proof of concept clinical
Medivir has announced that the first patient has been enrolled in a phase I study to investigate the safety and tolerability of a combination treatment of birinapant and radiation therapy
The company has announced results from a preclinical study examining ilixadencel, an off-the-shelf, cell-based immune primer, tested in combination with the immune checkpoint inhibitor CTLA-4. As Immunicum continues to advance
Data from a voluntary open label extension (OLE) study indicates longer PSA effect with Liproca Depot in prostate cancer patients than anticipated. In half of the patients it has taken
Sarah McGarrity’s research focuses on endothelial cells, which are important for blood pressure and clotting, and her findings might give us a better understanding and lead to treatments for conditions
Researchers at Karolinska Institutet have shown that the memory capacity and learning capability of mice improve if lithium treatment is given after the irradiation of the brain. Mice that were
Kaja Plucinska’s research focuses on the brown and beige fat secretome and the discovery of novel endocrine factors regulating insulin sensitivity and energy balance. Her findings might lead to new
Cemre Manav performs baseline scientific research in RNA processing that paves the way for new treatments of many diseases, such as heart failure, as well as for therapeutic processes, for
Cagla Sahin’s research focuses on expanding our knowledge of how the human memory is formed and stored, and she will investigate molecular interactions inside cellular structures formed by memory proteins
A study by researchers at Karolinska Institutet shows that a treatment adjustment algorithm based on lung function and symptoms in a mobile phone can be an efficient tool in managing
